WGS Analysis of COVID-19 Positive Patients

Vanda Pharmaceuticals79 enrolled

Overview

We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Coronavirus Infection COVID-19

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ability and acceptance to provide written informed consent and fluent in English. * Men or women between 18-100+ years, inclusive. * Willing to comply with study procedures. * SARS-CoV-2 positive test result as confirmed by a RT-PCR assay with a sputum or nasopharyngeal sample (either done prior to or at the screening visit).

Locations (1)

Vanda Investigational Site

Cleveland, Ohio, United States

Outcomes

Primary Outcomes

Associations with severity and outcomes

Clinical associations with human and viral genetics

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.